Currently, more than forty states have passed legislation allowing for some form of medical marijuana or cannabidiol (CBD) use for the treatment of intractable epilepsy and other conditions. Twenty-nine states and the District of Columbia have comprehensive medical cannabis programs, and seventeen states have passed legislation approving the use of CBD oil (but not medical marijuana) for eligible health conditions.
Access to CBD in states with medical cannabis programs varies depending on a variety of factors, including where the states are in the regulatory implementation process and what strains of cannabis are being cultivated by existing dispensaries. Many of the states with CBD-only laws do not allow for state regulated cultivation, production, and dispensing of CBD, making it hard for families to gain safe and legal access to this treatment option.
The Epilepsy Foundation supports policy proposals that allow for state regulated cultivation, production, and dispensing of cannabis and CBD. States can play a critical role in ensuring that access to CBD is safe and reliable so that families do not fall victims to unscrupulous individuals selling unsafe products marketed as CBD, or feel the need to consider breaking federal and state laws by traveling across state lines to obtain CBD oil in states where only residents are legally allowed access to this treatment.
Below are answers to frequently asked questions about access to medical cannabis access.